bioMérieux S.A. (BIM)

Basic

  • Market Cap

    €11.67B

  • EV

    €11.75B

  • Shares Out

    118.12M

  • Revenue

    €3,701.2M

  • Employees

    12,846

Margins

  • Gross

    55.93%

  • EBITDA

    20.85%

  • Operating

    15.74%

  • Pre-Tax

    13.44%

  • Net

    10.43%

  • FCF

    4.65%

Returns (5Yr Avg)

  • ROA

    8.67%

  • ROE

    15.64%

  • ROCE

    18.24%

  • ROIC

    14.09%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    €107.6

  • P/E

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

Per Share

  • Rev

    €31.41

  • Earnings (Dil)

    €3.25

  • FCF

    €1.45

  • Book Value

    €30.71

Growth (CAGR)

  • Rev 3Yr

    8.77%

  • Rev 5Yr

    9.76%

  • Rev 10Yr

    8.93%

  • Dil EPS 3Yr

    8.05%

  • Dil EPS 5Yr

    7.33%

  • Dil EPS 10Yr

    11.04%

  • Rev Fwd 2Yr

    4.75%

  • EBITDA Fwd 2Yr

    3.81%

  • EPS Fwd 2Yr

    7.56%

  • EPS LT Growth Est

    13.5%

Dividends

  • Yield

    —

  • Payout

    25.95%

  • DPS

    €0.85

  • DPS Growth 3Yr

    64.77%

  • DPS Growth 5Yr

    20.11%

  • DPS Growth 10Yr

    10.03%

  • DPS Growth Fwd 2Yr

    -1.31%

Select a metric from the list below to chart it

Dec '13
Dec '15
Dec '17
Dec '19
Dec '21
LTM
Metric
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
LTM

Total Revenues

2,421.3

2,674.8

3,118.2

3,376.2

3,589.1

3,701.2

Total Revenues % Chg.

5.8%

10.5%

16.6%

8.3%

6.3%

7.0%

Cost of Goods Sold, Total

1,119.0

1,208.2

1,364.5

1,375.4

1,580.4

1,631.3

Gross Profit

1,302.3

1,466.6

1,753.7

2,000.8

2,008.7

2,069.9

Selling General & Admin Expenses, Total

643.1

749.8

789.3

815.6

954.7

1,016.5

R&D Expenses

326.9

374.3

398.8

385.8

446.6

465.8

Amortization of Goodwill and Intangible Assets

—

—

—

30.5

38.0

38.0

Other Operating Expenses

-31.2

-45.9

-46.9

-44.6

-43.6

-32.9

Other Operating Expenses, Total

938.8

1,078.2

1,141.2

1,187.3

1,395.7

1,487.4

Operating Income

363.5

388.4

612.5

813.5

613.0

582.5

Interest Expense, Total

-19.7

-20.1

-24.9

-9.1

-4.1

-1.4

Interest And Investment Income

1.2

1.2

1.5

1.7

1.2

1.2

Net Interest Expenses

-18.5

-18.9

-23.4

-7.4

-2.9

-0.2

Income (Loss) On Equity Invest.

0.2

—

-0.2

-0.7

—

—

Currency Exchange Gains (Loss)

-5.5

-4.9

-5.7

-4.3

-1.4

3.9

Other Non Operating Income (Expenses)

-1.9

0.8

1.3

1.3

-2.2

-4.2

EBT, Excl. Unusual Items

337.8

365.4

584.5

802.4

606.5

582.0

Merger & Related Restructuring Charges

—

—

—

-0.9

-9.6

-9.6

Impairment of Goodwill

-17.5

-17.9

-17.5

-4.6

-29.0

-87.7

Gain (Loss) On Sale Of Investments

—

—

-0.6

0.6

—

—

Gain (Loss) On Sale Of Assets

—

—

—

—

12.8

12.8

Asset Writedown

—

—

—

-23.7

—

—

Other Unusual Items

0.2

—

-42.2

—

—

—

EBT, Incl. Unusual Items

320.5

347.5

524.2

773.8

580.7

497.5

Income Tax Expense

65.1

77.8

121.5

175.6

140.1

144.5

Earnings From Continuing Operations

255.4

269.7

402.7

598.2

440.6

353.0

Minority Interest

1.1

3.1

1.7

2.9

11.8

32.9

Net Income

256.5

272.8

404.4

601.1

452.4

385.9

Net Income to Common Incl Extra Items

256.5

272.8

404.4

601.1

452.4

385.9

Net Income to Common Excl. Extra Items

256.5

272.8

404.4

601.1

452.4

385.9

Total Shares Outstanding

117.8

118.3

118.1

118.3

118.0

118.1

Weighted Avg. Shares Outstanding

117.8

118.3

118.1

118.3

117.9

117.8

Weighted Avg. Shares Outstanding Dil

118.4

118.7

118.7

118.9

118.4

118.6

EPS

2.2

2.3

3.4

5.1

3.8

3.3

EPS Diluted

2.2

2.3

3.4

5.1

3.8

3.2

EBITDA

519.2

550.6

796.5

1,005.1

814.0

771.6